Literature DB >> 8832073

Tissue distribution of adenosine receptor mRNAs in the rat.

A K Dixon1, A K Gubitz, D J Sirinathsinghji, P J Richardson, T C Freeman.   

Abstract

1. A degree of ambiguity and uncertainty exists concerning the distribution of mRNAs encoding the four cloned adenosine receptors. In order to consolidate and extent current understanding in this area, the expression of the adenosine receptors has been examined in the rat by use of in situ hybridisation and the reverse transcription-polymerase chain reaction (RT-PCR). 2. In accordance with earlier studies, in situ hybridisation revealed that the adenosine A1 receptor was widely expressed in the brain, whereas A2A receptor mRNA was restricted to the striatum, nucleus accumbens and olfactory tubercle. In addition, A1 receptor mRNA was detected in large striatal cholinergic interneurones, 26% of these neurones were also found to express the A2A receptor gene. Central levels of mRNAs encoding adenosine A2B and A3 receptors were, however, below the detection limits of in situ hybridisation. 3. The more sensitive technique of RT-PCR was then employed to investigate the distribution of adenosine receptor mRNAs in the central nervous system (CNS) and a wide range of peripheral tissues. As a result, many novel sites of adenosine receptor gene expression were identified. A1 receptor expression has now been found in the heart, aorta, liver, kidney, eye and bladder. These observations are largely consistent with previous functional data. A2A receptor mRNA was detected in all brain regions tested, demonstrating that expression of this receptor is not restricted to the basal ganglia. In the periphery A2A receptor mRNA was also found to be more widely distributed than generally recognised. The ubiquitous distribution of the A2B receptor is shown for the first time, A2B mRNA was detected at various levels in all rat tissues studied. Expression of the gene encoding the adenosine A3 receptor was also found to be widespread in the rat, message detected throughout the CNS and in many peripheral tissues. This pattern of expression is similar to that observed in man and sheep, which had previously been perceived to possess distinct patterns of A3 receptor gene expression in comparison to the rat. 4. In summary, this work has comprehensively studied the expression of all the cloned adenosine receptors in the rat, and in so doing, resolves some of the uncertainty over where these receptors might act to control physiological processes mediated by adenosine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832073      PMCID: PMC1909676          DOI: 10.1111/j.1476-5381.1996.tb15561.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680.

Authors:  M F Jarvis; M Williams
Journal:  Eur J Pharmacol       Date:  1989-09-13       Impact factor: 4.432

2.  Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses.

Authors:  P J Richardson; S J Brown; E M Bailyes; J P Luzio
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

3.  Autoradiographic visualization of A1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine.

Authors:  R G Weber; C R Jones; M J Lohse; J M Palacios
Journal:  J Neurochem       Date:  1990-04       Impact factor: 5.372

4.  The cellular localization of adenosine receptors in rat neostriatum.

Authors:  S P Alexander; M Reddington
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

5.  Distribution of mRNA encoding the inwardly rectifying K+ channel, BIR1 in rat tissues.

Authors:  A K Dixon; A K Gubitz; M L Ashford; P J Richardson; T C Freeman
Journal:  FEBS Lett       Date:  1995-10-23       Impact factor: 4.124

6.  Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy.

Authors:  J P Bolam; B H Wainer; A D Smith
Journal:  Neuroscience       Date:  1984-07       Impact factor: 3.590

7.  Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine.

Authors:  R R Goodman; S H Synder
Journal:  J Neurosci       Date:  1982-09       Impact factor: 6.167

8.  Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.

Authors:  J W Daly; P Butts-Lamb; W Padgett
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

9.  Discrete distributions of adenosine receptors in mammalian retina.

Authors:  C Blazynski
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

10.  Functional characterization of the adenosine receptor mediating inhibition of peristalsis in the rat jejunum.

Authors:  D L Hancock; I M Coupar
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more
  126 in total

1.  Activation of Trk neurotrophin receptors in the absence of neurotrophins.

Authors:  F S Lee; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  Binding of adenosine receptor ligands to brain of adenosine receptor knock-out mice: evidence that CGS 21680 binds to A1 receptors in hippocampus.

Authors:  Linda Halldner; Luisa V Lopes; Elisabetta Daré; Karin Lindström; Björn Johansson; Catherine Ledent; Rodrigo A Cunha; Bertil B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-18       Impact factor: 3.000

3.  ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Authors:  Sylvie Duflot; Bárbara Riera; Sonia Fernández-Veledo; Vicent Casadó; Robert I Norman; F Javier Casado; Carme Lluís; Rafael Franco; Marçal Pastor-Anglada
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.

Authors:  B A Baldo; G F Koob; A Markou
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

5.  Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes.

Authors:  Jianjie Wang; Stevan P Whitt; Leona J Rubin; Virginia H Huxley
Journal:  Microcirculation       Date:  2005-06       Impact factor: 2.628

6.  Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor.

Authors:  Min Zhong; Wan-ling Song; Ye-chun Xu; Yang Ye; Lin-yin Feng
Journal:  Acta Pharmacol Sin       Date:  2015-02-09       Impact factor: 6.150

7.  Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.

Authors:  L Antonioli; M Fornai; O Awwad; G Giustarini; C Pellegrini; M Tuccori; V Caputi; M Qesari; I Castagliuolo; P Brun; M C Giron; C Scarpignato; C Blandizzi; R Colucci
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 8.  Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia.

Authors:  Annalisa Pinna; Marcello Serra; Micaela Morelli; Nicola Simola
Journal:  J Neural Transm (Vienna)       Date:  2018-02-02       Impact factor: 3.575

9.  Opiate-induced changes in brain adenosine levels and narcotic drug responses.

Authors:  M Wu; P Sahbaie; M Zheng; R Lobato; D Boison; J D Clark; G Peltz
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

10.  Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Authors:  Min Guo; Zhan-Guo Gao; Ryan Tyler; Tyler Stodden; Yang Li; Joseph Ramsey; Wen-Jing Zhao; Gene-Jack Wang; Corinde E Wiers; Joanna S Fowler; Kenner C Rice; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  J Med Chem       Date:  2018-11-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.